Oxotremorine antagonism by a hypothalamic hormone, melanocyte-stimulating hormone release-inhibiting factor (MIF).
D000109:Acetylcholine / Q000037:antagonists & inhibitors; D000818:Animals; D001259:Ataxia / Q000139:chemically induced / Q000517:prevention & control; D003967:Diarrhea / Q000139:chemically induced / Q000517:prevention & control; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D004336:Drug Antagonism; D006168:Guinea Pigs; D006801:Humans; D007030:Hypothalamo-Hypophyseal System / Q000502:physiology*; D007082:Ileum; D066298:In Vitro Techniques; D008297:Male; D009074:Melanocyte-Stimulating Hormones / Q000378:metabolism*; D051379:Mice; D008815:Mice, Inbred Strains; D010095:Oxotremorine / Q000037:antagonists & inhibitors; D012472:Salivation / Q000187:drug effects; D013666:Tears / Q000378:metabolism; D013981:Tic Disorders / Q000139:chemically induced / Q000517:prevention & control; D014202:Tremor / Q000139:chemically induced / Q000517:prevention & control; D014203:Tremorine / Q000037:antagonists & inhibitors*
D010095:Oxotremorine; D004295:Dihydroxyphenylalanine; D009074:Melanocyte-Stimulating Hormones; D000109:Acetylcholine; D014203:Tremorine